Emla Anesthetic Disc Interactions
There are 83 drugs known to interact with Emla Anesthetic Disc (lidocaine / prilocaine topical), along with 7 disease interactions. Of the total drug interactions, 43 are major, 33 are moderate, and 7 are minor.
- View all 83 medications that may interact with Emla Anesthetic Disc
- View Emla Anesthetic Disc disease interactions (7)
Most frequently checked interactions
View interaction reports for Emla Anesthetic Disc (lidocaine / prilocaine topical) and the medicines listed below.
- Accutane (isotretinoin)
- acetaminophen / hydrocodone
- acetylcysteine
- Acidophilus (lactobacillus acidophilus)
- Actonel (risedronate)
- Adderall (amphetamine / dextroamphetamine)
- Addyi (flibanserin)
- Advair Diskus (fluticasone / salmeterol)
- alfuzosin
- Alimta (pemetrexed)
- alprazolam
- amoxicillin
- Ativan (lorazepam)
- benzonatate
- cetirizine
- clindamycin topical
- desonide topical
- dicyclomine
- doxycycline
- fluconazole
- hydrocodone
- ibuprofen
- lisinopril
- Norco (acetaminophen / hydrocodone)
- prednisone
- ProAir HFA (albuterol)
- Protonix (pantoprazole)
- Singulair (montelukast)
- Zofran (ondansetron)
- Zoloft (sertraline)
Emla Anesthetic Disc disease interactions
There are 7 disease interactions with Emla Anesthetic Disc (lidocaine / prilocaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- methemoglobinemia
- renal/hepatic dysfunction
Report options
QR code containing a link to this page
More about Emla Anesthetic Disc (lidocaine / prilocaine topical)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.